Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. That is the view of UBS ...

From Intellect Design to Minda Corporation - here is a list of five stocks that analysts suggested buying for up to three ...

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

It's important to keep in mind that Buffett's words and actions don't always follow the path of the majority. This top ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation ...

Pfizer (NYSE: PFE) is an interesting healthcare company with excellent prospects for cash flow growth. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day.

Finbold asked ChatGPT which undervalued stocks of 2024 are worth tracking - and possibly investing in - in 2025.

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

Sangamo Therapeutics regains rights to its hemophilia A gene therapy as Pfizer ends their collaboration. The program showed ...

Sangamo said it plans to explore all options to commercialise the asset, including seeking a potential new collaboration partner.